James Merlit, Varghese Treesa P, Sharma Raghav, Chand Sharad
Department of Pharmacy Practice, NGSM Institute of Pharmaceutical Sciences, Nitte (Deemed to be University), Paneer, Deralakatte, Mangaluru, Karnataka 575018 India.
Department of General Medicine, Justice K.S. Hegde Charitable Hospital, Nitte (Deemed to be University), Deralakatte, Mangaluru, 575018 India.
J Diabetes Metab Disord. 2020 May 5;19(1):437-443. doi: 10.1007/s40200-020-00523-2. eCollection 2020 Jun.
Lifestyle changes in diabetes mellitus leads to metabolic syndrome, thus resulting in a hike in micro and macrovascular complications in diabetes mellitus patients. The main objective of the study was to identify the occurrence of metabolic syndrome and to evaluate the gender-associated difference in each component of metabolic syndrome by using International Diabetic Federation (IDF) and National Cholesterol Education Program Adult Treatment Panel III (NCEP ATP III)criteria.
This is a cross-sectional study conducted in 350 type II diabetes mellitus patients. All the study participants within 30-80 years were enrolled. Subjects with type I DM and pregnant women were excluded from the study.
The occurrence of metabolic syndrome among the diabetic population was found to be 42.28% and 28.85% using the IDF and the NCEP ATP III criteria respectively. It was observed that the prevalence was found to be higher in females than males as per IDF and NCEP ATP III criteria and was found to be statistically significant (p < 0.001). Central obesity elevated blood pressure, and reduced high-density lipoprotein was significantly higher in female patients. The most frequently occurring risk factor in this study population was central obesity followed by hypertension. A comparative analysis of IDF and NCEP ATP III criteria implies that when compared to diabetes patients without metabolic syndrome, all the metabolic risk elements were significantly higher in diabetes patients with metabolic syndrome.
This study concluded that the occurrence of metabolic syndrome was dreadfully high among the diabetic population, especially among female subjects.
糖尿病患者的生活方式改变会导致代谢综合征,进而使糖尿病患者的微血管和大血管并发症增加。本研究的主要目的是通过使用国际糖尿病联盟(IDF)和美国国家胆固醇教育计划成人治疗专家组第三次报告(NCEP ATP III)标准,确定代谢综合征的发生率,并评估代谢综合征各组成部分的性别差异。
这是一项对350例II型糖尿病患者进行的横断面研究。纳入所有年龄在30 - 80岁的研究参与者。I型糖尿病患者和孕妇被排除在研究之外。
分别采用IDF和NCEP ATP III标准,糖尿病患者中代谢综合征的发生率分别为42.28%和28.85%。据观察,根据IDF和NCEP ATP III标准,女性患病率高于男性,且具有统计学意义(p < 0.001)。女性患者中心性肥胖、血压升高和高密度脂蛋白降低的情况更为显著。本研究人群中最常见的危险因素是中心性肥胖,其次是高血压。对IDF和NCEP ATP III标准的比较分析表明,与无代谢综合征的糖尿病患者相比,有代谢综合征的糖尿病患者所有代谢风险因素均显著更高。
本研究得出结论,糖尿病患者中代谢综合征的发生率极高,尤其是女性患者。